The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lifestyle and outcomes after gastrointestinal cancer: A prospective cohort study (LOGIC).
 
Marissa Barbara Savoie
No Relationships to Disclose
 
Katherine Van Loon
Consulting or Advisory Role - Bayer (Inst)
 
Angela Laffan
No Relationships to Disclose
 
Andrea Grace Bocobo
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - Dendreon; Fortis
 
Alan T Paciorek
No Relationships to Disclose
 
Chloe Evelyn Atreya
Consulting or Advisory Role - Genentech; Kura Oncology
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Guardant Health; Merck; Novartis
Travel, Accommodations, Expenses - Roche
 
Mekhail Anwar
No Relationships to Disclose
 
Tami Rowen
No Relationships to Disclose
 
James F Smith
No Relationships to Disclose
 
Dianne Shumay
No Relationships to Disclose
 
Stacey A. Kenfield
No Relationships to Disclose
 
June M. Chan
Employment - GRAIL (I); Myriad Genetics (I)
Stock and Other Ownership Interests - GRAIL (I); Myriad Genetics (I)
Research Funding - GenomeDx (Inst); Genomic Health (Inst); GRAIL (I); Myriad Genetics (I)
 
Alan P. Venook
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences; Merrimack
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Merck Serono; Merrimack; Roche; Taiho Pharmaceutical
 
Erin Van Blarigan
No Relationships to Disclose